12th August 2023 (7 Topics)
1
Aug
2
Aug
3
Aug
4
Aug
5
Aug
7
Aug
8
Aug
9
Aug
10
Aug
11
Aug
12
Aug
14
Aug
15
Aug
16
Aug
17
Aug
18
Aug
19
Aug
21
Aug
22
Aug
23
Aug
24
Aug
25
Aug
26
Aug
28
Aug
29
Aug
30
Aug
31
Aug
The Right to Treatment
Context:
Drug-resistant tuberculosis (DR-TB) is a big challenge for India that demands urgent attention. With a quarter of the world’s DR-TB cases, India’s response can shape how other countries deal with this growing threat.
Drug resistant TB statistics for India:
- Continuously increasing burden: The WHO estimates that 119,000 new cases of multidrug/rifampicin resistant TB (MDR/RR-TB) emerge in India each year.
- Policy malfunction: The Indian TB programme has notified only a little over half the estimate about 64,000 MDR/RR-TB cases in 2022.
- Delayed Identification: However, last year in India, only about 23 per cent of those presumed with TB underwent few initial diagnostics tests.
Loopholes in India’s Policy:
- Gaps in TB diagnosis: Our inability to diagnose DR-TB rapidly is a huge gap which needs accurate tools for detection, medication and curing it.
- Ignoring BPaL regimen: India is the only global supplier of pretomanid, a key drug within the BPaL regimen. However, only 403 patients in India have so far been administered the pretomanid-containing BPaL regimen through a clinical trial.
- Century-old tools used for detection: Microscopy, which is now became old method and cannot detect drug-resistance, and detects only half of all people with these tests.
Efforts to overcome TB cases:
- WHO’s stand on BPaLM/BPaL: It has released a Standard on Universal Access to Rapid TB Diagnostics, recommending the use of molecular diagnostics as the initial test as these are highly accurate, detect resistance to drugs, are cost-effective, and reduce treatment-related delay.
- Modification in Drug usage: Shortening the duration of DR-TB treatment from 24 months to 6 months is a big improvement.
- Cost efficient method: Studies estimate an annual saving of 740 million dollars globally because of transition to BPaLM/BPaL.
You must be logged in to get greater insights. click here to login
Courses
Study
Notes
Home
Resources
More
